Novonesis' bid for Microbiogen under review in Australia
MLex Summary: Denmark-based biotechnology company Novonesis’ proposed acquisition of Sydney-based Microbiogen is under review by Australia's competition watchdog. Novonesis, which already holds a minority stake in Microbiogen, proposes to acquire the...To view the full article, register now.
Already a subscriber? Click here to view full article